2μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | Coagulation factor XI, FXI, PTA, F11 |
| Accession | P03951 |
| Amino Acid Sequence | Glu 19 - Val 625 with His Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 70-100kDa (Reducing) |
| Purity | >95% by SDS-PAGE & HPLC |
| Conjugation | Unconjugated |
| Tag | His Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, pH7.4, 5% trehalose |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | 1. Moellmer, S.A., et al. (2023). Biology of Factor XI. Blood. |
Background
Coagulation factor XI (FXI) is a key serine protease zymogen in the blood coagulation cascade. Unlike other clotting factors, FXI circulates in plasma as a homodimer composed of two identical polypeptide chains linked by disulfide bonds. Structurally, FXI comprises four N-terminal Apple domains responsible for binding to other coagulation factors and platelets, and a C-terminal catalytic domain that, upon activation, exerts its proteolytic function.
Activation of FXI is primarily mediated by activated FXIIa or thrombin. Once activated, FXIa subsequently activates FIX, thereby linking the extrinsic pathway to the contact activation pathway, amplifying thrombin generation, and promoting thrombus formation and stabilization. Importantly, the function of FXI extends beyond hemostasis; it plays a significant role in maintaining vascular barrier function, activating platelets, mediating inflammatory responses, and regulating immunity. Loss-of-function mutations in the F11 gene lead to a mild bleeding disorder known as Rosenthal syndrome.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of Coagulation factor XI / FXI His Tag Protein, Human with is more than 95% determined by SEC-HPLC.
RP-HPLC
The purity of Coagulation factor XI / FXI His Tag Protein, Human with is more than 95% determined by RP-HPLC.
ELISA
Immobilized Coagulation factor XI / FXI His Tag Protein, Human (Cat. No.UA016078) at 1.0μg/mL (100μL/well) can bind Anti-Human F11 / Factor XI Monoclonal Antibody (Abelacimab) (Cat. No. UA016089) with EC50 of 0.52-1.24 ng/mL.
Immobilized Anti-Human F11 / Factor XI Monoclonal Antibody (Abelacimab) (Cat. No. UA016089) at 1.0μg/mL (100μL/well) can bind Coagulation factor XI / FXI His Tag Protein, Human (Cat. No.UA016078) with EC50 of 4.73-6.60 ng/mL.
